Christopher R Brown Md Pulmonary is categorized under Pulmonary Doctors in San Francisco, CA and active since 1998.
Christopher R Brown Md Pulmonary was established in 1998, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Pulmonary Doctors business, which does work in the B2C market, and is classified as a Pulmonary Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Christopher R Brown at the company’s single location by writing to 2351 Clay St # 501, San Francisco, California CA 94115 or by phoning (415) 923-3421. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Christopher R Brown Md Pulmonary |
Contact Person: | Christopher R Brown |
Address: | 2351 Clay St # 501, San Francisco, California 94115 |
Phone Number: | (415) 923-3421 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 1998 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Pulmonary Doctors |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Christopher R Brown Md Pulmonary was started in 1998 to provide professional Pulmonary Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Christopher R Brown for inquiries that concern Christopher R Brown Md Pulmonary by calling the company number (415) 923-3421, as your correspondence is most welcome. Additionally, the physical location of the single location of Christopher R Brown Md Pulmonary can be found at the coordinates 37.790844,-122.432144 as well as the street address 2351 Clay St # 501 in San Francisco, California 94115.
For its online presence, you may visit Christopher R Brown Md Pulmonary’s website at and engage with its social media outlets through on Twitter and on Facebook.